Pathophysiology, etiologic factors, and clinical management of oral lichen planus, part I: facts and controversies

Clinics in Dermatology

Volumn 28, Issue 1, 2010, Pages 100-108

  Farhi, David ^a   Dupin, Nicolas ^a  

^a APHP ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CLOBETASOL; CLOBETASOL PROPIONATE; CORTICOSTEROID; CYCLOSPORIN; ETRETINATE; FLUOCINOLONE ACETONIDE; FLUOCINONIDE ACETONIDE; KETOCONAZOLE; MICONAZOLE; PIMECROLIMUS; PLACEBO; PREDNISONE; RETINOIC ACID; RETINOID; STEROID; TACROLIMUS; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE; UNCLASSIFIED DRUG; VIRUS RNA;

AGE DISTRIBUTION; ALCOHOL ABSTINENCE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; BURNING SENSATION; CANCER SCREENING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; DESQUAMATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG WITHDRAWAL; DRY SKIN; ERYTHEMA; FOLLOW UP; GENETIC PREDISPOSITION; GRAFT VERSUS HOST REACTION; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HYPERKERATOSIS; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; KERATINOCYTE; LICHEN PLANUS; LYMPHOCYTIC INFILTRATION; MALIGNANT TRANSFORMATION; MEDITERRANEAN SEA; MOUTH CANCER; MOUTH HYGIENE; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PATIENT MONITORING; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; SEX DIFFERENCE; SKIN IRRITATION; SKIN MANIFESTATION; SMOKING CESSATION; THRUSH;

ADRENAL CORTEX HORMONES; ADULT; AGED; CELL TRANSFORMATION, NEOPLASTIC; EVIDENCE-BASED MEDICINE; FEMALE; HEPATITIS C; HUMANS; LICHEN PLANUS, ORAL; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; RISK FACTORS; YOUNG ADULT;

EID: 71749098735     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2009.03.004     Document Type: Article

References (145)

1. Pindborg J.J., Reichart P.A., Smith C.I., et al. WHO International Histological Classification of Tumours. Histological Typing of cancer and precancer of the oral mucosa (1997), Springer, Berlin
2. Miller C.S., Epstein J.B., Hall E.H., et al. Changing oral care needs in the United States: the continuing need for oral medicine. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 91 (2001) 34-44
3. Bouquot J.E., and Gorlin R.J. Leukoplakia, lichen planus, and other oral keratoses in 23,616 white Americans over the age of 35 years. Oral Surg Oral Med Oral Pathol 61 (1986) 373-381
4. Axell T., and Rundquist L. Oral lichen planus-a demographic study. Community Dent Oral Epidemiol 15 (1987) 52-56
5. Murti P.R., Daftary D.K., Bhonsle R.B., et al. Malignant potential of oral lichen planus: observations in 722 patients from India. J Oral Pathol 15 (1986) 71-77
6. Eisen D. The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients. J Am Acad Dermatol 46 (2002) 207-214
7. Mollaoglu N. Oral lichen planus: a review. Br J Oral Maxillofac Surg 38 (2000) 370-377
8. Eisen D. The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 88 (1999) 431-436
9. Rogers R.S. III, Eisen D. Erosive oral lichen planus with genital lesions: the vulvovaginal-gingival syndrome and the peno-gingival syndrome. Dermatol Clin 2003;21:91-8, vi-vii.
10. Scully C., and Carrozzo M. Oral mucosal disease: lichen planus. Br J Oral Maxillofac Surg 46 (2008) 15-21
11. Altman J., and Perry H.O. The variations and course of lichen planus. Arch Dermatol 84 (1961) 179-191
12. Hallopeau H. Sur un cas de lichen de Wilson gingival avec neoplasie voisine dans la région maxillaire. Bull Soc Fr Dermatol Syphiligr 17 (1910) 32
13. Lodi G., Scully C., Carrozzo M., et al. Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 100 (2005) 164-178
14. Rajentheran R., McLean N.R., Kelly C.G., et al. Malignant transformation of oral lichen planus. Eur J Surg Oncol 25 (1999) 520-523
15. Bornstein M.M., Kalas L., Lemp S., et al. Oral lichen planus and malignant transformation: a retrospective follow-up study of clinical and histopathologic data. Quintessence Int 37 (2006) 261-271
16. Gandolfo S., Richiardi L., Carrozzo M., et al. Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population. Oral Oncol 40 (2004) 77-83
17. Hietanen J., Paasonen M.R., Kuhlefelt M., et al. A retrospective study of oral lichen planus patients with concurrent or subsequent development of malignancy. Oral Oncol 35 (1999) 278-282
18. Hsue S.S., Wang W.C., Chen C.H., et al. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital. J Oral Pathol Med 36 (2007) 25-29
19. Ingafou M., Leao J.C., Porter S.R., et al. Oral lichen planus: a retrospective study of 690 British patients. Oral Dis 12 (2006) 463-468
20. Rodstrom P.O., Jontell M., Mattsson U., et al. Cancer and oral lichen planus in a Swedish population. Oral Oncol 40 (2004) 131-138
21. Roosaar A., Yin L., Sandborgh-Englund G., et al. On the natural course of oral lichen lesions in a Swedish population-based sample. J Oral Pathol Med 35 (2006) 257-261
22. van der Meij E.H., Mast H., and van der Waal I. The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective five-year follow-up study of 192 patients. Oral Oncol 43 (2007) 742-748
23. Zhang L., Michelsen C., Cheng X., et al. Molecular analysis of oral lichen planus. A premalignant lesion. Am J Pathol 151 (1997) 323-327
24. van der Meij E.H., Schepman K.P., Smeele L.E., et al. A review of the recent literature regarding malignant transformation of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 88 (1999) 307-310
25. Epstein J.B., Wan L.S., Gorsky M., et al. Oral lichen planus: progress in understanding its malignant potential and the implications for clinical management. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 96 (2003) 32-37
26. Lo Muzio L., Mignogna M.D., Favia G., et al. The possible association between oral lichen planus and oral squamous cell carcinoma: a clinical evaluation on 14 cases and a review of the literature. Oral Oncol 34 (1998) 239-246
27. Sugerman P.B., Satterwhite K., and Bigby M. Autocytotoxic T-cell clones in lichen planus. Br J Dermatol 142 (2000) 449-456
28. Rich A.M., and Reade P.C. A quantitative assessment of Langerhans cells in oral mucosal lichen planus and leukoplakia. Br J Dermatol 120 (1989) 223-228
29. Farthing P.M., and Cruchley A.T. Expression of MHC class II antigens (HLA DR, DP and DQ) by keratinocytes in oral lichen planus. J Oral Pathol Med 18 (1989) 305-309
30. Kang K., Kubin M., Cooper K.D., et al. IL-12 synthesis by human Langerhans cells. J Immunol 156 (1996) 1402-1407
31. Muller G., Saloga J., Germann T., et al. Identification and induction of human keratinocyte-derived IL-12. J Clin Invest 94 (1994) 1799-1805
32. Simark Mattsson C., Jontell M., Bergenholtz G., et al. Distribution of interferon-gamma mRNA-positive cells in oral lichen planus lesions. J Oral Pathol Med 27 (1998) 483-488
33. Simark-Mattsson C., Bergenholtz G., Jontell M., et al. Distribution of interleukin-2, -4, -10, tumour necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus. Arch Oral Biol 44 (1999) 499-507
34. Lodi G., Scully C., Carrozzo M., et al. Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 100 (2005) 40-51
35. Khan A., Farah C.S., Savage N.W., et al. Th1 cytokines in oral lichen planus. J Oral Pathol Med 32 (2003) 77-83
36. Sugerman P.B., Savage N.W., Walsh L.J., et al. Disease mechanisms in oral lichen planus. A possible role for autoimmunity. Australas J Dermatol 34 (1993) 63-69
37. Potts A.J., Hamburger J., and Scully C. The medication of patients with oral lichen planus and the association of nonsteroidal anti-inflammatory drugs with erosive lesions. Oral Surg Oral Med Oral Pathol 64 (1987) 541-543
38. Robertson W.D., and Wray D. Ingestion of medication among patients with oral keratoses including lichen planus. Oral Surg Oral Med Oral Pathol 74 (1992) 183-185
39. Thompson D.F., and Skaehill P.A. Drug-induced lichen planus. Pharmacotherapy 14 (1994) 561-571
40. Ismail S.B., Kumar S.K., and Zain R.B. Oral lichen planus and lichenoid reactions: etiopathogenesis, diagnosis, management and malignant transformation. J Oral Sci 49 (2007) 89-106
41. Imanguli M.M., Alevizos I., Brown R., et al. Oral graft-versus-host disease. Oral Dis 14 (2008) 396-412
42. Mohty M., Kuentz M., Michallet M., et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood 100 (2002) 3128-3134
43. Flowers M.E., Parker P.M., Johnston L.J., et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood 100 (2002) 415-419
44. Demarosi F., Soligo D., Lodi G., et al. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 100 (2005) 63-69
45. Carrozzo M., Francia Di Celle P., Gandolfo S., et al. Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus-associated oral lichen planus. Br J Dermatol 144 (2001) 803-808
46. Carrozzo M., Uboldi de Capei M., Dametto E., et al. Tumor necrosis factor-alpha and interferon-gamma polymorphisms contribute to susceptibility to oral lichen planus. J Invest Dermatol 122 (2004) 87-94
47. Ghodratnama F., Wray D., and Bagg J. Detection of serum antibodies against cytomegalovirus, varicella zoster virus and human herpesvirus 6 in patients with recurrent aphthous stomatitis. J Oral Pathol Med 28 (1999) 12-15
48. Boyd A.S., Annarella M., Rapini R.P., et al. False-positive polymerase chain reaction results for human papillomavirus in lichen planus. Potential laboratory pitfalls of this procedure. J Am Acad Dermatol 35 (1996) 42-46
49. Gonzalez-Moles M.A., Rodriguez-Archilla A., Ruiz Avila I., et al. Presence of HPV 16 sequences in oral lichen planus lesions. Bull Group Int Rech Sci Stomatol & Odontol 40 (1998) 92-97
50. Jontell M., Watts S., Wallstrom M., et al. Human papilloma virus in erosive oral lichen planus. J Oral Pathol Med 19 (1990) 273-277
51. Kashima H.K., Kutcher M., Kessis T., et al. Human papillomavirus in squamous cell carcinoma, leukoplakia, lichen planus, and clinically normal epithelium of the oral cavity. Ann Otol Rhinol Laryngol 99 (1990) 55-61
52. Ceballos-Salobrena A., Aguirre-Urizar J.M., and Bagan-Sebastian J.V. Oral manifestations associated with human immunodeficiency virus infection in a Spanish population. J Oral Pathol Med 25 (1996) 523-526
53. Ficarra G., Flaitz C.M., Gaglioti D., et al. White lichenoid lesions of the buccal mucosa in patients with HIV infection. Oral Surg Oral Med Oral Pathol 76 (1993) 460-466
54. Mokni M., Rybojad M., Puppin Jr. D., et al. Lichen planus and hepatitis C virus. J Am Acad Dermatol 24 (1991) 792
55. Bagan J.V., Ramon C., Gonzalez L., et al. Preliminary investigation of the association of oral lichen planus and hepatitis C. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 85 (1998) 532-536
56. Carrozzo M., Gandolfo S., Carbone M., et al. Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. J Oral Pathol Med 25 (1996) 527-533
57. Erkek E., Bozdogan O., and Olut A.I. Hepatitis C virus infection prevalence in lichen planus: examination of lesional and normal skin of hepatitis C virus-infected patients with lichen planus for the presence of hepatitis C virus RNA. Clin Exp Dermatol 26 (2001) 540-544
58. Gimenez-Garcia R., and Perez-Castrillon J.L. Lichen planus and hepatitis C virus infection. J Eur Acad Dermatol Venereol 17 (2003) 291-295
59. Kirtak N., and Inaloz H.S. Ozgoztasi, et al. The prevalence of hepatitis C virus infection in patients with lichen planus in Gaziantep region of Turkey. Eur J Epidemiol 16 (2000) 1159-1161
60. Mignogna M.D., Lo Muzio L., Favia G., et al. Oral lichen planus and HCV infection: a clinical evaluation of 263 cases. Int J Dermatol 37 (1998) 575-578
61. Rebora A. Hepatitis viruses and lichen planus. Arch Dermatol 130 (1994) 1328-1329
62. Sanchez-Perez J., De Castro M., Buezo G.F., et al. Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection. Br J Dermatol 134 (1996) 715-719
63. Nagao Y., Sata M., Tanikawa K., et al. Lichen planus and hepatitis C virus in the northern Kyushu region of Japan. Eur J Clin Invest 25 (1995) 910-914
64. Beaird L.M., Kahloon N., Franco J., et al. Incidence of hepatitis C in lichen planus. J Am Acad Dermatol 44 (2001) 311-312
65. Bellman B., Reddy R.K., and Falanga V. Lichen planus associated with hepatitis C. Lancet 346 (1995) 1234
66. Chuang T.Y., Stitle L., Brashear R., et al. Hepatitis C virus and lichen planus: A case-control study of 340 patients. J Am Acad Dermatol 41 (1999) 787-789
67. Cribier B., Garnier C., Laustriat D., et al. Lichen planus and hepatitis C virus infection: an epidemiologic study. J Am Acad Dermatol 31 (1994) 1070-1072
68. Dupin N., Chosidow O., Lunel F., et al. Oral lichen planus and hepatitis C virus infection: a fortuitous association?. Arch Dermatol 133 (1997) 1052-1053
69. Ingafou M., Porter S.R., Scully C., et al. No evidence of HCV infection or liver disease in British patients with oral lichen planus. Int J Oral Maxillofac Surg 27 (1998) 65-66
70. Tucker S.C., and Coulson I.H. Lichen planus is not associated with hepatitis C virus infection in patients from north west England. Acta Derm Venereol 79 (1999) 378-379
71. Ibrahim H.A., Baddour M.M., Morsi M.G., et al. Should we routinely check for hepatitis B and C in patients with lichen planus or cutaneous vasculitis?. East Mediterr Health J 5 (1999) 71-78
72. Daramola O.O., George A.O., and Ogunbiyi A.O. Hepatitis C virus and lichen planus in Nigerians: any relationship?. Int J Dermatol 41 (2002) 217-219
73. Lodi G., Giuliani M., Majorana A., et al. Lichen planus and hepatitis C virus: a multicentre study of patients with oral lesions and a systematic review. Br J Dermatol 151 (2004) 1172-1181
74. Grote M., Reichart P.A., Berg T., et al. Hepatitis C virus (HCV)-infection and oral lichen planus. J Hepatol 29 (1998) 1034-1035
75. Henderson L., Muir M., Mills P.R., et al. Oral health of patients with hepatitis C virus infection: a pilot study. Oral Dis 7 (2001) 271-275
76. Mignogna M.D., Fedele S., Lo Russo L., et al. Unexpected low incidence of oral lichen planus in an HCV hyperendemic area of southern Italy. Gastroenterology 121 (2001) 1528-1529
77. Nagao Y., Sata M., Fukuizumi K., et al. High incidence of oral lichen planus in an HCV hyperendemic area. Gastroenterology 119 (2000) 882-883
78. Nagao Y., Tanaka J., Nakanishi T., et al. High incidence of extrahepatic manifestations in an HCV hyperendemic area. Hepatol Res 22 (2002) 27-36
79. Nylander K., Coates P.J., and Hall P.A. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. Int J Cancer 87 (2000) 368-372
80. Pawlotsky J.M., Ben Yahia M., Andre C., et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 19 (1994) 841-848
81. Petruzzi M., De Benedittis M., Loria M.P., et al. Immune response in patients with oral lichen planus and HCV infection. Int J Immunopathol Pharmacol 17 (2004) 93-98
82. Jubert C., Pawlotsky J.M., Pouget F., et al. Lichen planus and hepatitis C virus-related chronic active hepatitis. Arch Dermatol 130 (1994) 73-76
83. Arrieta J.J., Rodriguez-Inigo E., Casqueiro M., et al. Detection of hepatitis C virus replication by In situ hybridization in epithelial cells of anti-hepatitis C virus-positive patients with and without oral lichen planus. Hepatology 32 (2000) 97-103
84. Carrozzo M., Quadri R., Latorre P., et al. Molecular evidence that the hepatitis C virus replicates in the oral mucosa. J Hepatol 37 (2002) 364-369
85. Nagao Y., Sata M., Noguchi S., et al. Detection of hepatitis C virus RNA in oral lichen planus and oral cancer tissues. J Oral Pathol Med 29 (2000) 259-266
86. Pilli M., Penna A., Zerbini A., et al. Oral lichen planus pathogenesis: A role for the HCV-specific cellular immune response. Hepatology 36 (2002) 1446-1452
87. Roy K.M., Dickson E.M., Staines K.S., et al. Hepatitis C virus and oral lichen planus/lichenoid reactions: lack of evidence for an association. Clin Lab 46 (2000) 251-254
88. Pawlotsky J.M., Benchiki H., Pellet C., et al. Lichen planus and hepatitis C virus (HCV)-related chronic hepatitis: evaluation of HCV genotypes. Br J Dermatol 133 (1995) 666-667
89. Nagao Y., Sata M., Itoh K., et al. Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus. Eur J Clin Invest 26 (1996) 495-498
90. Lodi G., Carrozzo M., Hallett R., et al. HCV genotypes in Italian patients with HCV-related oral lichen planus. J Oral Pathol Med 26 (1997) 381-384
91. Lodi G., Olsen I., Piattelli A., et al. Antibodies to epithelial components in oral lichen planus (OLP) associated with hepatitis C virus (HCV) infection. J Oral Pathol Med 26 (1997) 36-39
92. Carrozzo M., Gandolfo S., Lodi G., et al. Oral lichen planus in patients infected or noninfected with hepatitis C virus: the role of autoimmunity. J Oral Pathol Med 28 (1999) 16-19
93. Bagan J.V., Aguirre J.M., del Olmo J.A., et al. Oral lichen planus and chronic liver disease: a clinical and morphometric study of the oral lesions in relation to transaminase elevation. Oral Surg Oral Med Oral Pathol 78 (1994) 337-342
94. el-Kabir M., Scully C., Porter S., et al. Liver function in UK patients with oral lichen planus. Clin Exp Dermatol 18 (1993) 12-16
95. Zakrzewska J.M., Chan E.S., and Thornhill M.H. A systematic review of placebo-controlled randomized clinical trials of treatments used in oral lichen planus. Br J Dermatol 153 (2005) 336-341
96. Al-Hashimi I, Schifter M, Lockhart PB, et al. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 2007;103(suppl):S25 e1-12.
97. Eisen D., Carrozzo M., Bagan Sebastian J.V., et al. Number V Oral lichen planus: clinical features and management. Oral Dis 11 (2005) 338-349
98. Mattsson U., Jontell M., and Holmstrup P. Oral lichen planus and malignant transformation: is a recall of patients justified?. Crit Rev Oral Biol Med 13 (2002) 390-396
99. Chan E.S., Thornhill M., and Zakrzewska J. Interventions for treating oral lichen planus. Cochrane Database Syst Rev (2000) CD001168
100. Snyder R.A., Schwartz R.A., Schneider J.S., et al. Intermittent megadose corticosteroid therapy for generalized lichen planus. J Am Acad Dermatol 6 (1982) 1089-1090
101. Silverman Jr. S., Lozada-Nur F., and Migliorati C. Clinical efficacy of prednisone in the treatment of patients with oral inflammatory ulcerative diseases: a study of fifty-five patients. Oral Surg Oral Med Oral Pathol 59 (1985) 360-363
102. Carbone M., Goss E., Carrozzo M., et al. Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up. J Oral Pathol Med 32 (2003) 323-329
103. Vincent S.D., Fotos P.G., Baker K.A., et al. Oral lichen planus: the clinical, historical, and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol 70 (1990) 165-171
104. Lo Muzio L., della Valle A., Mignogna M.D., et al. The treatment of oral aphthous ulceration or erosive lichen planus with topical clobetasol propionate in three preparations: a clinical and pilot study on 54 patients. J Oral Pathol Med 30 (2001) 611-617
105. Lozada-Nur F., Miranda C., and Maliksi R. Double-blind clinical trial of 0.05% clobetasol propionate (corrected from proprionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol 77 (1994) 598-604
106. Sardella A., Demarosi F., Oltolina A., et al. Efficacy of topical mesalazine compared with clobetasol propionate in treatment of symptomatic oral lichen planus. Oral Dis 4 (1998) 255-259
107. Conrotto D., Carbone M., Carrozzo M., et al. Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial. Br J Dermatol 154 (2006) 139-145
108. Thongprasom K., Luangjarmekorn L., Sererat T., et al. Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus. J Oral Pathol Med 21 (1992) 456-458
109. Voute A.B., Schulten E.A., Langendijk P.N., et al. Fluocinonide in an adhesive base for treatment of oral lichen planus. A double-blind, placebo-controlled clinical study. Oral Surg Oral Med Oral Pathol 75 (1993) 181-185
110. Carbone M., Conrotto D., Carrozzo M., et al. Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide. Oral Dis 5 (1999) 44-49
111. Randell S., and Cohen L. Erosive lichen planus. Management of oral lesions with intralesional corticosteroid injections. J Oral Med 29 (1974) 88-91
112. Zegarelli DJ. Topical and intralesional steroid therapy of oral lichen planus. N Y State Dent J 1980;46:432,4-6.
113. Eisen D., Griffiths C.E., Ellis C.N., et al. Cyclosporin wash for oral lichen planus. Lancet 335 (1990) 535-536
114. Frances C., Boisnic S., Etienne S., et al. Effect of the local application of ciclosporine A on chronic erosive lichen planus of the oral cavity. Dermatologica 177 (1988) 194-195
115. Epstein J.B., and Truelove E.L. Topical cyclosporine in a bioadhesive for treatment of oral lichenoid mucosal reactions: an open label clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 82 (1996) 532-536
116. Levell N.J., Munro C.S., and Marks J.M. Severe lichen planus clears with very low-dose cyclosporin. Br J Dermatol 127 (1992) 66-67
117. Sieg P., Von Domarus H., Von Zitzewitz V., et al. Topical cyclosporin in oral lichen planus: a controlled, randomized, prospective trial. Br J Dermatol 132 (1995) 790-794
118. Eisen D., Ellis C.N., Duell E.A., et al. Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis. N Engl J Med 323 (1990) 290-294
119. Lener E.V., Brieva J., Schachter M., et al. Successful treatment of erosive lichen planus with topical tacrolimus. Arch Dermatol 137 (2001) 419-422
120. Morrison L., Kratochvil III F.J., and Gorman A. An open trial of topical tacrolimus for erosive oral lichen planus. J Am Acad Dermatol 47 (2002) 617-620
121. Vente C., Reich K., Rupprecht R., et al. Erosive mucosal lichen planus: response to topical treatment with tacrolimus. Br J Dermatol 140 (1999) 338-342
122. Olivier V., Lacour J.P., Mousnier A., et al. Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study. Arch Dermatol 138 (2002) 1335-1338
123. Radfar L., Wild R.C., and Suresh L. A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 105 (2008) 187-193
124. Laeijendecker R., Tank B., Dekker S.K., et al. A comparison of treatment of oral lichen planus with topical tacrolimus and triamcinolone acetonide ointment. Acta Derm Venereol 86 (2006) 227-229
125. Kaliakatsou F., Hodgson T.A., Lewsey J.D., et al. Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus. J Am Acad Dermatol 46 (2002) 35-41
126. Rozycki T.W., Rogers III R.S., Pittelkow M.R., et al. Topical tacrolimus in the treatment of symptomatic oral lichen planus: a series of 13 patients. J Am Acad Dermatol 46 (2002) 27-34
127. Niwa Y., Terashima T., and Sumi H. Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin. Br J Dermatol 149 (2003) 960-967
128. Becker J.C., Houben R., Vetter C.S., et al. The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report. BMC Cancer 6 (2006) 7
129. Passeron T., Lacour J.P., Fontas E., et al. Treatment of oral erosive lichen planus with 1% pimecrolimus cream: a double-blind, randomized, prospective trial with measurement of pimecrolimus levels in the blood. Arch Dermatol 143 (2007) 472-476
130. Swift J.C., Rees T.D., Plemons J.M., et al. The effectiveness of 1% pimecrolimus cream in the treatment of oral erosive lichen planus. J Periodontol 76 (2005) 627-635
131. Gorouhi F., Solhpour A., Beitollahi J.M., et al. Randomized trial of pimecrolimus cream versus triamcinolone acetonide paste in the treatment of oral lichen planus. J Am Acad Dermatol 57 (2007) 806-813
132. Sloberg K., Hersle K., Mobacken H., et al. Severe oral lichen planus: remission and maintenance with vitamin A analogues. J Oral Pathol 12 (1983) 473-477
133. Petruzzi M., De Benedittis M., Grassi R., et al. Oral lichen planus: a preliminary clinical study on treatment with tazarotene. Oral Dis 8 (2002) 291-295
134. Gunther S.H. Vitamin A acid in treatment of oral lichen planus. Arch Dermatol 107 (1973) 277
135. Hersle K., Mobacken H., Sloberg K., et al. Severe oral lichen planus: treatment with an aromatic retinoid (etretinate). Br J Dermatol 106 (1982) 77-80
136. Camisa C., and Allen C.M. Treatment of oral erosive lichen planus with systemic isotretinoin. Oral Surg Oral Med Oral Pathol 62 (1986) 393-396
137. Woo TY. Systemic isotretinoin treatment of oral and cutaneous lichen planus. Cutis 1985;35:385-6, 90-1, 93.
138. Laurberg G., Geiger J.M., Hjorth N., et al. Treatment of lichen planus with acitretin. A double-blind, placebo-controlled study in 65 patients. J Am Acad Dermatol 24 (1991) 434-437
139. Ott F., Bollag W., and Geiger J.M. Efficacy of oral low-dose tretinoin (all-trans-retinoic acid) in lichen planus. Dermatology 192 (1996) 334-336
140. Buajeeb W., Kraivaphan P., and Pobrurksa C. Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 83 (1997) 21-25
141. Schuppli R. The efficacy of a new retinoid (Ro 10-9359) in lichen planus. Dermatologica 157 suppl 1 (1978) 60-63
142. Gorsky M., and Raviv M. Efficacy of etretinate (Tigason) in symptomatic oral lichen planus. Oral Surg Oral Med Oral Pathol 73 (1992) 52-55
143. Boisnic S., Branchet M.C., Pascal F., et al. [Topical tretinoin in the treatment of lichen planus and leukoplakia of the mouth mucosa. A clinical evaluation]. Ann Dermatol Venereol 121 (1994) 459-463
144. Giustina T.A., Stewart J.C., Ellis C.N., et al. Topical application of isotretinoin gel improves oral lichen planus. A double-blind study. Arch Dermatol 122 (1986) 534-536
145. Guyot A.D., Farhi D., Ingen-Housz-Oro S., et al. Treatment of refractory erosive oral lichen planus with extracorporeal photochemotherapy: 12 cases. Br J Dermatol 156 (2007) 553-556